Jesse Bloom PRO
Scientist studying evolution of proteins and viruses.
Jesse Bloom
Fred Hutch Cancer Center / HHMI
These slides: https://slides.com/jbloom/nasem-h5
Influenza pandemics have occurred for at least 500 years (Morens et al, 2010). Most recently:
1918: animal virus (maybe from birds?) jumped to humans (dos Reis, 2009)
1957: avian virus reassorted HA / NA / PB1 with human strain (Palese, 2004)
1968: avian virus reassorted HA / PB1 with human strain (Palese, 2004)
1977: inadvertant human release of strain from ~1950s (Burke & Schleunes, 2024)
2009: swine virus jumped to humans (Smith et al, 2009)
In 1872, influenza caused major outbreaks in poultry and horses, but likely never spread in humans beyond sporadic cases (Morens & Taubenberger, 2010)
There are multiple influenza strains in pigs that so far have only caused sporadic human cases (Anderson et al, 2021)
Influenza has caused substantial outbreaks in dogs without infecting humans (Parrish, 2015)
There would be precedent for H5N1 adapting to cause a human pandemic...
But there would also be precedent for it never adapting to transmit in humans...
Viral polymerase functions well in mammalian cells (Long et al, 2019)
HA binds human receptors (Matrosovich, 2000; Ayora-Talavera, 2009)
Higher HA stability (Imai, 2012; Herfst, 2012)
Nucleoprotein resistant to MxA and BTN3A3 (Manz et al, 2013, Pinto 2023)
Appropriately balanced HA-NA activity (Yen, 2011)
Probably other adaptations that are not well understood
Viral polymerase functions well in mammalian cells (Halwe et al, 2024)
HA binds human receptors (Santos et al, 2024; Chopra et al, 2024)
Higher HA stability (Peacock et al, 2024)
Nucleoprotein resistant to MxA and BTN3A3
Appropriately balanced HA-NA activity
Probably other adaptations that are not well understood
Yes
No
(at least so far)
Unknown
(at least in public literature to date)
Test transmission in ferrets or growth in human airway cultures. Experimental gold standard---but slow, low throughput, and requires high biosafety. (Restori et al, 2024)
Test HA for binding to different glycans. Very informative, but only about receptor specificity. (Chopra et al, 2024)
Deep mutational scanning to test how all mutations affect key properties. High throughput, but may not capture epistasis or all relevant properties. (Dadonaite et al, 2024)
(These scenarios are not mutually exclusive)
Cattle mammary gland may not select for viruses that use human receptors, which could reduce chance of scenario 1 (Carrasco, 2024)
One way to ensure vaccines are available quickly is to prepare candidate vaccine viruses, or even stockpile vaccines.
But as influenza HA acquires mutations, these candidate vaccines can become poorly matched to the actual viruses of concern.
Deep mutational scanning data from Dadonaite et al (2024)
Carefully track antigenic changes in HA and update candidate vaccine viruses accordingly
Develop vaccine platforms that can be rapidly tailored to new strains (Furey et al, 2024)
1. Understand how influenza has evolved in the past
2. Identify and monitor for potential adaptations to humans
3. Ensure well-matched vaccines could be produced quickly
By Jesse Bloom
Presentation for Oct-22-2024 NASEM workshop on research priorities for H5N1